Riverwater Partners’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
ACM
AIC
Riverwater Partners's ABEO Position: Q3 2026 in Review
Riverwater Partners held its Abeona Therapeutics (ABEO) position steady in Q3 2026 at 24,304 shares worth $128K. The position accounts for 0.04% of the portfolio, ranked #206.
Riverwater Partners first reported a position in ABEO in Q2 2025 and has held it in 6 quarters since. The position peaked at $150K in Q2 2026. 116 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.
- Riverwater Partners held 24,304 shares of Abeona Therapeutics worth $128K as of Q3 2026.
- Riverwater Partners left its Abeona Therapeutics share count unchanged in Q3 2026.
- Abeona Therapeutics made up 0.04% of Riverwater Partners's portfolio in Q3 2026, its #206 holding.
- Riverwater Partners first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 6 quarters since.
- Riverwater Partners's Abeona Therapeutics position peaked at $150K in Q2 2026.
- 116 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.
Based on Riverwater Partners's 13F filing for Q3 2026, filed 3 Nov 2026.